Relationship between chronic pain and cognition in cognitively intact older persons and patients with Alzheimer's disease; the need to control for mood by Scherder, E.J.A. et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Behavioural Science Section 
 Gerontology 2008;54:50–58 
 DOI: 10.1159/000113216 
 Relationship between Chronic Pain and Cognition 
in Cognitively Intact Older Persons and in Patients 
with Alzheimer’s Disease 
 The Need to Control for Mood 
 Erik J.A. Scherder a    Laura Eggermont a    Bart Plooij a    Jeroen Oudshoorn a    
Pieter Jelle Vuijk c    Gisèle Pickering e    Stefan Lautenbacher f     Wilco Achterberg b    
Joukje Oosterman d 
 a  Department of Clinical Neuropsychology, VU University  Amsterdam ,  b  EMGO Institute and Department of Nursing
Home Medicine, VU University Medical Center,  Amsterdam ,  c  Institute of Human Movement Sciences, 
Rijksuniversiteit Groningen,  Groningen , and  d  Department of Experimental Psychology, Helmholtz Institute,
Utrecht University, Utrecht, The Netherlands;  e  Clinical Pharmacology Center,  Clermont-Ferrand , France; 
 f  Physiological Psychology, Otto Friedrich University of Bamberg,  Bamberg , Germany 
intact older persons. Cognition, in particular memory, ap-
peared to be related to depressive symptoms. In contrast, a 
significant positive correlation was observed between EF, 
pain intensity and pain affect measured by the FPS in the AD 
group.  Conclusions: Although older persons with depres-
sion were excluded, in studies on pain and cognition one 
should control for the presence of depressive symptoms in 
older persons with and without dementia. 
 Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 There is ample evidence, irrespective of an individu-
al’s cognitive status, that aging is associated with a high 
incidence of painful conditions  [1] . Since age is also the 
major risk factor for dementia  [2] and the aging society 
increases, it is likely that the number of dementia patients 
experiencing painful conditions increases as well  [3] .
 The assessment of pain in dementia is complicated by 
the observation that pain experience, or a possible change 
in such experience, may depend on the specific subtype 
of dementia involved. For example, a subgroup of patients 
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 Abstract 
 Background: Brain areas that are involved in cognition and 
mood also play a role in pain processing.  Objective: The goal 
of the present study was to examine the relationship be-
tween chronic pain and cognition [executive functions (EF) 
and memory], while controlling for mood, in cognitively in-
tact older persons and in patients with Alzheimer’s disease 
(AD).  Methods: Two groups of subjects participated: 20 old-
er persons without dementia and 19 patients in an early 
stage of probable AD who suffered from arthrosis/arthritis. 
Pain intensity and pain affect were assessed by the Colored 
Analogue Scale for Pain Intensity and for Pain Affect, the Fac-
es Pain Scale (FPS) and the Number of Words Chosen-Affec-
tive (NWC-A). Level of depression and anxiety were evaluat-
ed by questionnaires. EF and memory were assessed by 
neuropsychological tests.  Results: The results show that sig-
nificant correlations between specific cognitive functions, 
pain intensity and pain affect were lacking in the cognitively 
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with Alzheimer’s disease (AD) and patients with fronto-
temporal dementia gave indications of experiencing a de-
crease in the affective aspects of pain. Conversely, an in-
crease in these aspects was observed in patients with vas-
cular dementia  [4] . These findings suggest that a possible 
change in pain experience depends on the specific neu-
ropathology that is characteristic of the dementia sub-
type in question. A neuropathological hallmark of AD is 
degeneration of the hippocampus and prefrontal cortex 
(PFC)  [5–7] . These brain areas and related neuronal cir-
cuits are involved in the processing of affective aspects of 
pain, cognitive-evaluative aspects of pain, pain memory 
and in the anticipation of affective painful stimuli  [8–11] . 
Consequently, neuropathology in these areas and related 
neuronal circuits, such as the frontohippocampal circuit, 
may account for the decreased experience of pain ob-
served in a subgroup of AD patients  [4] . The cholinergic 
innervation of the hippocampus by the septum, one of 
the basal forebrain areas, underscores a functional rela-
tionship between the frontal lobe and the hippocampus 
 [12] . The cholinergic neurotransmitter system is severely 
affected in patients with AD  [12] , and a recent experi-
mental animal study showed that depletion of the cholin-
ergic system in mice resulted in a deficit in pain memory, 
for example  [13] .
 Next to pain, it is known that neuronal circuits, such 
as the prefrontal-hippocampal circuit, are involved in 
mood, e.g. depression and anxiety  [14, 15] . Of note is that 
a relationship between depressive symptoms, anxiety and 
pain has been described in several studies  [16–18] , but has 
never been examined in AD patients, as far as we know.
 It is noteworthy that besides pain and mood, the fron-
tohippocampal circuit also plays a crucial role in  specific 
cognitive processes like executive functions (EF) and 
memory  [19] . A positive correlation between  global cog-
nitive functioning, as measured by the Mini-Mental State 
Examination (MMSE)  [20] , and anticipatory autonomic 
responses to pain was demonstrated in a recent study 
 [21] .
 The goal of the present study was to examine the rela-
tionship between chronic pain and cognition in cogni-
tively intact older persons and in patients with AD, while 
controlling for mood.
 Subjects and Methods 
 Subjects 
 The sample consisted of 20 older persons without dementia (4 
males and 16 females) and 19 AD patients (2 males and 17 females) 
in a relatively early stage, i.e. stage 5 of the Global Deterioration 
Scale  [22] , randomly selected from a sample of 500 elderly persons 
who live in a residential home. The age of the AD group (mean = 
86.37, SD = 5.29, range 74–93 years) did not significantly differ 
from the age of the older persons without dementia (mean = 85.70, 
SD = 6.42, range 79–103 years): t(37) = 0.35, p = 0.73. Further-
more, the two groups did not differ in gender (  2 = 0.87, d.f. = 1, 
p = 0.65).
 The older persons without dementia and the AD group were 
screened for education (five categories: elementary school not fin-
ished: score = 1; elementary school: score = 2; lower secondary 
school: score = 3; higher secondary school: score = 4; higher 
 vocational training for 18+/university: score = 5): mean = 2.74
(SD = 0.99) and 2.70 (SD = 0.73), respectively. Both groups did not 
differ with respect to education [t(37) = 0.13, p = 0.90].
 All AD patients met the criteria of the National Institute of 
Neurological and Communicative Diseases and Stroke/Alzhei-
mer’s Disease and Related Disorders Association (NINCDS-
ADRDA) for the clinical diagnosis of probable AD  [23] . Subjects 
were excluded from participation in this study if they had vision 
problems, a history of psychiatric disorders, particularly depres-
sion, alcoholism, cerebral trauma, transient ischemic attack, hy-
drocephalus, neoplasm, epilepsy, disturbances of consciousness 
or focal brain disorders.
 Global cognitive functioning was assessed by means of the 20-
item MMSE (maximum score: 30)  [20] . The MMSE evaluates ori-
entation in time and place, registration, recall, attention and cal-
culation, language and praxis, and visuoconstructive abilities. 
Considering the high mean age of the participants, an MMSE 
score of  ^  23 was considered indicative for cognitive impairment 
 [24] . As expected, the mean MMSE score of the AD group (19.63, 
SD = 1.77, range 17–24) and of the control group (27.30, SD = 1.95, 
range 24–30) differed significantly [t(37) = 12.84, p  ! .001]. One 
person in the AD group had an MMSE score of 24. However, the 
clinical diagnosis of the nursing home physician and the results 
of the neuropsychological examination justified the inclusion of 
that person into the AD group.
 Comorbidity. The prevalence of specific categories of illness in 
both groups was compared to exclude the possibility of an un-
equal distribution of pain-inducing diseases. Specific categories 
of illness were heart disease, cardiovascular risk factors (hyper-
tension and diabetes mellitus), peripheral vascular disease, lung 
disease, chronic renal failure, tumors, ulcers, anemia, hyper-/hy-
pothyroidism, cholecystectomy, hearing and vision problems, 
urological diseases, Dupuytren’s disease, migraine, diverticulo-
sis, esophagitis, liver disturbances, psoriasis and Menière’s dis-
ease. For each separate category of illness, comparisons were 
made between the two groups by means of   2 tests. Data analyses 
showed that there was no difference in the prevalence of specific 
categories of illness between both groups.
 Characteristics of Painful Conditions. A prerequisite for par-
ticipation in the study was that the participants had to suffer from 
arthrosis/arthritis of one of the joints at the lower extremity or at 
the lumbar spine. The medical records were kept by the former 
general practitioner and by the present nursing home physician. 
Presence of arthrosis/arthritis was determined by having the 
medical records reviewed by one of the authors (E.J.A.S.).
 Vital and Gnostic Sensitivity. To control for possible changes 
in the sensory-discriminative aspects of pain, vital and gnostic 
sensitivity were tested.  Vital sensitivity  was tested by (1) pinprick, 
i.e. a needle with a blunt and a sharp side applied to the dorsal side 
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of both hands and to the forearms; (2) touch, assessed by touching 
the subject with a cotton wool and by touching the subject with 
one or two fingers at the same time (simultaneous extinction), 
and (3) temperature, assessed by applying two glass tubes filled 
with cold and hot water.  Gnostic sensitivity  was tested by passive-
ly moving one finger of the subject in a certain position, either 
bent or stretched. With closed eyes, the subject had to indicate the 
finger and its position. This procedure was applied to both hands. 
During these four tests (3 for vital sensitivity and 1 for gnostic 
sensitivity), the subjects were asked to close their eyes. A distur-
bance in each of the four conditions had a score of 1 (max. score: 
4). The three separate vital sensitivity scores were summed up to 
form a total vital sensitivity score. Data analyses showed that the 
total vital sensitivity score did not differ significantly between 
both groups [t(37) = 0.65, p = 0.52]. Similar findings were ob-
served for gnostic sensitivity [t(37) = 0.07, p = 0.95].
 Informed Consent. The participants and their family were ex-
tensively informed about the aim and procedure of this investiga-
tion; subsequently, they gave their informed consent. A local 
medical ethical committee approved the study.
 Methods 
 Assessment of Depression and Anxiety 
 Since depression and anxiety may show a relationship with 
both cognitive functioning  [18] and pain  [16, 17] , the Beck De-
pression Inventory (BDI)  [25] and the subscale Anxiety of the 
Symptom Checklist-90 (SCL-90)  [26] , Dutch version  [27] , were 
administered. The BDI consists of 21 questions; the score on each 
question ranges from 0 to 3, resulting in a maximum score of 63. 
The BDI can be divided into three subscales: the BDI subscale Af-
fect (8 items: sadness, pessimism, dissatisfaction, suicidal ideas, 
crying, irritability, indecisiveness and weight loss), the BDI sub-
scale Physical Function (7 items: social withdrawal, work diffi-
culty, insomnia, fatigability, loss of appetite, somatic preoccupa-
tion and loss of libido) and the BDI subscale Self-Denigration (6 
items: sense of failure, guilt, punishment, self-dislike, self-accusa-
tions and body image change)  [28] .
 The SCL-90 is a standardized questionnaire, assessing physi-
cal and mental functioning through self-evaluation. The subscale 
Anxiety (10 items) has a maximum score of 50.
 Assessment of Specific Cognitive Functions 
 Various neuropsychological tests have been administered to 
assess memory and EF; the administration of the tests took place 
only once, to avoid test-retest effects.
 Memory 
 Digit Span Forward is a subtest of the Wechsler Memory Scale 
 [29] . In this condition, the subjects are asked to repeat a sequence 
of digits (range 3–8) in the same order as read aloud by the exam-
iner. This subtest measures short-term memory and attention, 
and has a maximum score of 21.
 The Eight Words Test of the Amsterdam Dementia Screening 
test  [30] was applied to assess verbal episodic memory. The  Im-
mediate Recall subtest consists of the total number of correct 
words after 5 trials (maximum score: 40). The  Delayed Recall sub-
test is composed of the total number of words that are correctly 
reproduced after an interval of approximately 10 minutes; this 
subtest measures particularly active retrieval from memory store 
(maximum score: 8). In the  Recognition subtest, the participant 
had to recognize the original 8 words from a set of 16 words. The 
recognition score is the total of correct responses (maximum 
score: 16).
 Faces Recognition of the Rivermead Behavioral Memory Test 
 [31] is a visual, nonverbal long-term episodic memory test. The 
test consists of a set of 10 pictures of different faces (extended ver-
sion). Each card is presented in a fixed order during 4 s. After an 
interval of 5 min, subjects had to select the original 10 faces from 
a set of 20 cards. The score is the number of correct responses 
(maximum score: 20).
 Picture Recognition of the Rivermead Behavioral Memory Test 
 [31] measures the visual-verbal long-term episodic memory. The 
test consists of 20 cards (extended version) showing line drawings 
of various objects; each card is presented for 4 s in a fixed order. 
The subjects were asked to name the object on the cards. After a 
5-min interval, a set of 40 cards was presented and the subjects 
had to select the original 20 cards. The score is the number of cor-
rect responses (maximum score: 40).
 Memory Domain.  The raw scores of the above-mentioned tests 
were transformed into z-scores and subsequently summed up to 
compose the memory domain (Cronbach’s   : 0.86).
 Executive Functions  
 With respect to EF, the following neuropsychological tests 
were included.
 Digit Span Backward  is another subtest of the Wechsler Mem-
ory Scale  [29] . In this condition, the subjects have to repeat a se-
quence of digits that are read aloud by the examiner in a reversed 
order. Besides attention, this subtest is a measure of working 
memory (maximum score: 21).
 In  Category Fluency , a subtest  from the Dutch Groninger Intel-
ligence Test  [32] , subjects have to name as many words as possible 
from two different categories: animals and professions. The total 
score for each category is the number of correct words, produced 
in 60 s.
 Knox’s Cube Imitation Test  [33] assesses visuospatial working 
memory. Four wooden blocks are placed in front of the subject. 
The examiner ticks on a number of blocks, in a predetermined 
order, which must be replicated by the subject. The number of 
blocks gradually increases. The score is the number of correct re-
sponses (maximum score: 15).
 Incomplete Figures is also a subtest of the Groninger Intelli-
gence Test  [32] . The test consists of 22 incomplete figures which 
can only be named by using one’s closure capacity. The degree of 
vagueness of the incomplete figures increases during the test. The 
score is the number of correct responses (maximum score: 20).
 EF Domain.  The raw scores of the above-mentioned tests were 
transformed into z-scores and subsequently summed up to com-
pose the EF domain (Cronbach’s   : 0.70).
 Assessment of Pain Intensity and Pain Affect 
 To assess pain intensity and pain affect, three visual analogue 
scales and one pain questionnaire were administered. To increase 
reliability, pain assessment took place twice, with a time interval 
of approximately 1 month. The three visual analogue scales are 
described in the following.
 The Colored Analogue Scale (CAS) for Assessment of Pain In-
tensity . The CAS is meant to assess primarily the intensity of pain 
in a nonverbal way  [34] . The different scale positions are marked 
by different colors (pink at the bottom: no pain, and deep red at 
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the top: maximum pain) and areas which facilitate the subject’s 
selection of a scale position which best reflects his/her pain inten-
sity  [34] . Selecting the appropriate scale position takes place by 
sliding a horizontal marker from the bottom to the top. The sub-
ject’s score is the numerical value on the back of the scale which 
matches the selected scale position (range 0–100 mm;  fig. 1 ).
 CAS for Assessment of Pain Affect. The original CAS  [34] was 
modified and used to assess the affective aspects of pain. The label 
‘no pain’ at the bottom was replaced by the label ‘no suffering’ and 
the label ‘maximum pain’ at the top by the label ‘a great deal of 
suffering’. Similar to the original CAS, each scale position re-
ferred to a number (a numerical value) which was on the back of 
the scale. The subject’s scores ranged from 1 to 100 mm.
 The Faces Pain Scale (FPS) . The FPS is meant to measure both 
pain intensity and pain affect  [35] . This scale can be reliably and 
validly administered to children as young as 3 years of age. More-
over, recent findings show that AD patients remain the capacity 
to process facial emotions  [36] , a prerequisite for a reliable admin-
istration of the FPS. The FPS consists of line drawings of seven 
faces, i.e. one neutral face and six faces which express increasing 
feelings of pain. Each face is 6 cm high. The faces are rank ordered 
from 0 to 6, from left to right. Subjects could rank their feelings 
from ‘no pain’ (score 0, the neutral face, at the extreme left side) 
to most severe pain (score 6, the face expressing most feelings of 
pain, at the extreme right side;  fig. 2 ). The subject’s score is identi-
cal to the scale number, i.e. ranging from 0 to 6.
 Comprehension of the Visual Analogue Scales 
 Participants were tested for their comprehension of the con-
cept. For the CAS Pain Intensity/CAS Pain Affect they were asked 
to move the marker to the level that reflects the most severe pain/
the most suffering (top of the scale) or no pain at all/no suffering 
(bottom of the scale). For the FPS, they were asked to indicate 
which face showed the most severe pain and which face showed 
no pain.
 The Pain Questionnaire:  the Number of Words Chosen-Affec-
tive (NWC-A) of the McGill Pain Questionnaire  [37] (Dutch ver-
sion  [38] ): this affective pain scale consists of five items, with 
each comprising three affective adjectives. The items are ar-
ranged by increasing intensity (ranking), which allows the sub-
jects to indicate the nature of the pain (e.g. worry or depression). 
The adjectives of the NWC-A were read aloud by the examiner. 
By adding the results of this scale, a maximum score of 15 could 
emerge.
 Data Analyses 
 Since the data were not normally distributed, square root 
transformation was used. If both groups showed a significant dif-
ference concerning depressive symptoms and anxiety, data on 
cognitive function and pain experience would be analyzed by 
means of analyses of covariance with depressive symptoms and 
anxiety as covariates in both groups. Effect sizes were estimated 
by the partial   2 and interpreted as: small (  2  ; 0.01), medium 
(  2  ; 0.06) and large (  2  1 0.13), following Cohen’s  [39]  standard. 
As only the first pain measurement took place together with the 
assessment of cognitive functioning and mood in AD patients 
and older persons without dementia, the relationship between 
these variables was further explored by Spearman’s correlation. 
Only in case of a significant correlation, linear regression analysis 
was performed. A Bonferroni correction was applied to control 
for multiple comparisons, resulting in a p value of  ! 0.005 that was 
considered significant. The SPSS program was used for data anal-
yses  [40] .
 Results 
 Depression and Anxiety 
 To provide insight into the extent depressive symp-
toms were present in both groups, first the mean scores, 
standard deviations and t tests are provided for the scores 
on the three subscales of the BDI and for the total BDI 
score. The mean scores on the BDI subscales Affect and 
Physical Function of the control group were significantly 
higher than those of the AD group. The mean score on 
the BDI subscale Self-Denigration did not differ between 
both groups.
 Furthermore, the scores on the SCL-90 subscale Anx-
iety appeared not to differ between the AD group and the 
control group. For means, standard deviations and t tests, 
see  table 1 .
 Fig. 1. CAS for the assessment of pain in-
tensity (in cm). 
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 Cognitive Functioning 
 As expected, data analyses by means of univariate 
analysis of covariance (ANCOVA) with depressive symp-
toms (BDI) as covariate indicated that AD patients had a 
significantly lower score than older persons without de-
mentia on the memory domain [F(1,31) = 40.96, p  ! 
0.001]. Similarly, AD patients scored significant lower 
than the older persons without dementia on the EF do-
main [F(1,33) = 16.26, p  ! 0.001].
 Pain Intensity and Pain Affect 
 First Pain Measure.  An analysis of variance with de-
pressive symptoms (BDI) as a covariate (ANCOVA) 
showed significantly lower scores on the CAS Pain Inten-
sity 1, FPS 1 and NWC-A 1 in the AD patients compared 
to the older persons without dementia. The effect sizes 
were large. The means, standard deviations and ANCO-
VA of the scores on all four pain scales are presented in 
 table 2 .
 Second Pain Measure.  The extent to which patients 
and controls indicated to suffer from pain was in close 
agreement with the first moment of pain measurement 
( table 2 ). The score on CAS Pain Affect 2 was now sig-
nificantly lower in the AD group compared to the older 
persons without dementia.
 Relationships between Pain Intensity, Pain Affect, 
EF, Memory, Depressive Symptoms and Anxiety in 
Patients with AD 
 Data analyses by means of Spearman’s correlations 
showed only a significant relationship between the EF 
domain and FPS 1 (see  table 3 for Spearman’s correlations 
and levels of significance). Based on the above-mentioned 
significant correlation, a linear regression analysis was 
performed to predict the scores on the FPS 1 from the EF 
domain. The standardized regression equation for pre-
dicting the FPS is:
 Predicted Z FPS 1 = 0.713Z EF domain 
 Accuracy in predicting FPS 1 was high. The multiple 
correlation between FPS 1 and the EF domain was sig-
nificant (R 2 = 0.509) [F(1,15) = 15.55, p = 0.001]. In other 
words, 51% of the variance in FPS 1 was accounted for by 
its linear relationship with the EF domain.
 Fig. 2. FPS to measure pain intensity and pain affect. 
Table 1. Means, standard deviations, and t tests concerning the scores on the three subscales of the BDI and the 
SCL-90 subscale Anxiety of patients with AD and older persons without dementia
Depression
Anxiety 
AD patients Older persons
without dementia
t tests
mean SD mean SD t d.f. p
BDI 
Affect 2.11 2.23 4.50 3.40 2.59 37 0.014 
Physical Function 2.37 2.24 4.60 2.11 3.20 37 0.003 
Self-Denigration 0.37 0.83 0.65 1.27 0.82 37 0.42 
Total score 4.26 4.17 9.75 5.39 3.54 37 0.001 
SCL-90 Anxiety 12.91 4.35 13.75 4.02 0.63 37 0.54 
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 Relationships between Pain Intensity, Pain Affect,
EF, Memory, Depressive Symptoms and Anxiety in 
Older Persons without Dementia 
 Spearman’s correlations showed one significant rela-
tionship: the relationship between the EF domain and the 
memory domain ( table 3 ).
 Discussion 
 Depression and Anxiety 
 The results show that overall (total BDI score) older 
persons without dementia showed more depressive 
symptoms than AD patients. It is justified to speak of 
depressive symptoms as a total BDI score of  ! 10 is in-
dicative for minimal depression  [41] . More specifically, 
older persons without dementia scored higher on the 
BDI subscales Affect and Physical Function but not on 
the BDI subscale Self-Denigration. Of note is that a low 
score on the BDI subscale Self-Denigration is typical for 
chronic pain patients and not for patients with a major 
depression who show a high score on this BDI subscale 
 [28] ; chronic pain patients were also included in the pres-
ent study.
 As somatic complaints (BDI subscale Physical Func-
tion) including pain are related to anxiety in nursing 
home residents  [42] , one might have expected that the 
score on the SCL-90 subscale Anxiety was higher for the 
Table 3. Spearman’s correlations in the first pain measurement 
EF
domain
Memory
domain
CAS pain
intensity
CAS pain
affect
FPS NWC-A
AD patients 
EF domain – –0.042 0.473 0.474 0.675** 0.129
Memory domain –0.042 – 0.420 0.432 0.117 0.152
BDI 0.149 0.173 0.214 0.178 0.051 0.060
SCL-90 Anxiety –0.398 –0.170 –0.060 –0.106 –0.255 0.325
Older persons without dementia
EF domain – 0.689** –0.105 –0.380 –0.174 –0.336
Memory domain 0.689** – –0.043 –0.287 –0.428 –0.287
BDI –0.231 –0.557* 0.203 0.342 0.410 0.401
SCL-90 Anxiety –0.052 0.077 0.011 –0.059 0.067 0.132
* p < 0.03; ** p < 0.005.
Table 2. Means, standard deviations and analyses of variance concerning the scores on the various pain scales, 
with the scores on the BDI as a covariate, of patients with AD and older persons without dementia
Pain scales AD patients Older persons
without dementia
ANCOVA
mean SD mean SD F d.f. p< 2
CAS Pain Intensity 1 21.55 22.69 50.85 23.24 10.89 1.34 0.002 0.37
CAS Pain Intensity 2 27.00 29.67 45.89 23.36 7.77 1.34 0.009 0.19
CAS Pain Affect 1 15.79 21.34 41.20 29.01 2.14 2.36 0.132 0.11
CAS Pain Affect 2 20.89 27.17 40.83 27.59 4.77 1.34 0.036 0.12
FPS 1 0.56 0.70 2.39 1.69 10.63 1.32 0.001 0.39
FPS 2 0.79 1.05 2.33 1.45 10.43 1.27 0.003 0.28
NWC-A 1 2.00 2.69 4.42 2.67 10.92 1.34 0.002 0.23
NWC-A 2 2.35 3.64 3.78 3.00 3.98 1.33 0.054 0.11
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older persons without dementia than for those with AD; 
this appeared not to be the case. One explanation emerg-
es from animal experimental studies that show that AD 
neuropathology is responsible for the presence of anxiety 
 [43] . In other words, not pain but the AD process itself 
may have increased the score on the SCL-90 subscale 
Anxiety to a level similar to that of the older persons 
without dementia.
 Pain Experience 
 In agreement with the results of previous clinical stud-
ies  [44–46] , it was observed in the present study, irrespec-
tive of the moment of pain measurement (1 or 2), that the 
level of experienced pain intensity and pain affect report-
ed by AD patients was less than the level reported by old-
er persons without dementia. However, although in the 
previous studies AD patients and older persons with a 
depression were excluded, we did not control for the pres-
ence of depressive symptoms. Consequently, a relation-
ship between depressive symptoms and pain within each 
group has not been examined in those studies. The pres-
ent study did examine such a relationship which may 
shed a different light on previous findings, as will be ad-
dressed in the next sections.
 Relationship between EF, Memory, Pain,
Depressive Symptoms and Anxiety in AD 
 First, the lack of a correlation between EF and mem-
ory in AD patients suggests a decline in the functional 
relationship between the PFC and the hippocampus, re-
spectively. A dysfunction of the hippocampal-prefron-
tal circuit has been observed in AD  [47] and might be 
due to hippocampal neuropathology, which is more se-
vere than the neuropathology of the PFC in AD  [48] . 
Indeed, the present findings show only a significant 
positive relationship between EF and the FPS1, although 
the positive correlations between EF and CAS Pain In-
tensity and between memory, CAS Pain Intensity and 
CAS Pain Affect are also quite considerable. A signifi-
cant positive relationship between EF and FPS1 implies 
that the better EF, the more pain intensity and pain af-
fect the patient experiences. Of note is that the PFC plays 
a crucial role in EF  [49] , pain experience  [10] and face 
recognition  [50] . In addition, the PFC is involved in pro-
cessing facial expressions of emotions  [51] , important 
for the application of the FPS. The correlations between 
depression, anxiety, pain intensity and pain affect were 
low.
 Relationship between EF, Memory, Pain, Depressive 
Symptoms and Anxiety in Older Persons without 
Dementia 
 In the present study, a nearly significant relationship 
between EF and memory was observed (p = 0.008), sup-
porting an active prefrontal-hippocampal neuronal cir-
cuit. Nevertheless, a significant positive relationship be-
tween EF, memory and pain experience was lacking ( ta-
ble 3 ). We argue that the depressive symptoms, which 
were mild but significantly higher in this group than in 
the AD group, were responsible for this finding. For ex-
ample, a negative correlation was observed between de-
pression and memory (rho: –0.557, p  ! 0.02), implying 
that the more depressive symptoms, the lower the mem-
ory performance. This suggestion has been confirmed in 
a recent study which observed a causal relationship be-
tween depression and cognition in community-dwelling 
older persons, i.e. depression may cause a decline in cog-
nitive functioning  [18] . Furthermore, positive correla-
tions were observed between depression, CAS Pain In-
tensity, CAS Pain Affect, FPS 1 and NWC-A. The exis-
tence of a reciprocal relationship between pain and 
depression, i.e. pain may be a major cause of depression, 
but depression may also be a risk factor for the onset of 
pain, has been described in a recent study  [52] .
 Conclusions 
 Results from studies that indicate that, compared to 
controls, AD patients suffer less from pain  [44–46] should 
be considered with caution. The results of the present 
study show that although patients with depression were 
excluded, depressive symptoms may still be present, even 
more in the non-demented group. Indeed, depressive 
symptoms do occur in older persons without dementia, 
although often unrecognized  [53] , and may cause an in-
crease in pain experience  [17] .
 The high predictive value of EF for scores on the FPS 
1 (reflecting pain intensity and pain affect) suggests that 
a neuropsychological examination might contribute to 
pain assessment. It is known that the PFC plays a major 
though not an exclusive role in EF  [54] ; areas such as the 
cerebellum and striatum are involved in EF, too  [54, 55] . 
However, the cerebellum and striatum are also involved 
in the processing of painful stimuli  [56, 57] . It is therefore 
argued that the performance on EF tasks is indicative for 
the functioning of neuronal circuits that also play a role 
in pain processing.
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